Last reviewed · How we verify

StellaLife — Competitive Intelligence Brief

StellaLife (StellaLife) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical oral protective agent. Area: Oncology (supportive care).

marketed Topical oral protective agent Oncology (supportive care) Small molecule Live · refreshed every 30 min

Target snapshot

StellaLife (StellaLife) — Stony Brook University. StellaLife is a topical oral rinse that provides symptomatic relief and promotes healing of oral mucositis by creating a protective barrier and reducing inflammation in the oral cavity.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
StellaLife TARGET StellaLife Stony Brook University marketed Topical oral protective agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical oral protective agent class)

  1. Stony Brook University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). StellaLife — Competitive Intelligence Brief. https://druglandscape.com/ci/stellalife. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: